ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Fe3+-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma

Xiao, Youmei; Xu, Zhanxue; Cheng, Yuan; Huang, Rufan; Xie, Yuan; Tsai, Hsiang-i; Zha, Hualian; Xi, Lifang; Wang, Kai; Cheng, Xiaoli; Gao, Yanfeng; Zhang, Changhua*; Cheng, Fang*; Chen, Hongbo*南方医科大学; 江苏大学; 中山大学
BIOMATERIALS RESEARCH2023-7-1DOI: 10.1186/s40824-023-00401-x
5被引13阅读
引用收藏
分享

摘要

Background Ferroptosis, iron-dependent cell death, is an established mechanism for cancer suppression, particularly in hepatocellular carcinoma (HCC). Sorafenib (SOR), a frontline drug for the treatment of HCC, induces ferroptosis by inhibiting the Solute Carrier family 7 member 11 (SLC7A11), with inadequate ferroptosis notably contributing to SOR resistance in tumor cells.Methods To further verify the biological targets associated with ferroptosis in HCC, an analysis of the Cancer Genome Atlas (TCGA) database was performed to find a significant co-upregulation of SLC7A11 and transferrin receptor (TFRC), Herein, cell membrane-derived transferrin nanovesicles (TF NVs) coupled with Fe3+ and encapsulated SOR (SOR@TF-Fe3+ NVs) were established to synergistically promote ferroptosis, which promoted the iron transport metabolism by TFRC/TF-Fe3+ and enhanced SOR efficacy by inhibiting the SLC7A11.Results In vivo and in vitro experiments revealed that SOR@TF-Fe3+ NVs predominantly accumulate in the liver, and specifically targeted HCC cells overexpressing TFRC. Various tests demonstrated SOR@TF-Fe3+ NVs accelerated Fe3+ absorption and transformation in HCC cells. Importantly, SOR@TF-Fe3+ NVs were more effective in promoting the accumulation of lipid peroxides (LPO), inhibiting tumor proliferation, and prolonging survival rates in HCC mouse model than SOR and TF- Fe3+ NVs alone.Conclusions The present work provides a promising therapeutic strategy for the targeted treatment of HCC.

学科与关键词

关键词
TransferrinBiomembrane-based nanovesiclesSorafenibFerroptosisHepatocellular carcinomaCombination therapy
相关
加载中…
  • Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma
    Huang, Ziyue; Xia, Haoming; Cui, Yunfu; Yam, Judy Wai Ping*; Xu, Yi*Journal of Clinical and Translational Hepatology, 2023, 11(1): 207-218.被引 10
  • ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma
    Huang, Wenbin; Chen, Kunling; Lu, Yishi; Zhang, Donghui; Cheng, Yuan; Li, Liuran; Huang, Weimei; He, Guolin; Liao, Hangyu; Cai, Lei; Tang, Yujun; Zhao, Liang*; Pan, MingxinNeoplasia, 2021, 23(12): 1227-1239.被引 59
  • ATF3 promotes ferroptosis in sorafenib-induced cardiotoxicity by suppressing Slc7a11 expression
    Li, Yilan; Yan, Jingru; Zhao, Qianqian; Zhang, Yan; Zhang, YaoFrontiers in Pharmacology, 2022, 13: 904314.被引 21
查看全部 →

发表信息

论文状态
公开发表
期刊
BIOMATERIALS RESEARCH
发表日期
2023-07-01
卷期
第 27 卷, 第 1 期
页码
63
DOI
10.1186/s40824-023-00401-x
成果收录
SCIE
资助标注
National Key Ramp;D Program of China (China) [2022YFA1104900]; Science,Technology amp; Innovation Commission of Shenzhen Municipality (China) [2022A1515012214, JCYJ20210324120007020]; National Natural Science Foundation of China (China) [JCYJ20200109142605909, 81970145]; Natural Science Foundation of Guangdong Province (China) [82001698, 2020A1515011465, 2020A151501467]; Science,Technology amp; Innovation Commission of Shenzhen Municipality [2021B1212040006]; Open Fund of Guangdong Provincial Key Laboratory of Digestive Cancer Research (China) [SKLRD-OP-202303]; Open project of State Key Laboratory of Respiratory Diseases (China) [SKLRD-OP-202305, 2022M723678]; China Postdoctoral Foundation Science Foundation [ZSQYRSFPD0047]; Postdoctoral Foundation of The Seventh Affiliated Hospital of Sun Yat-Sen University; [JCYJ20190807151609464]

作者

  • X

    Xiao, Youmei (第一作者)

    sun yat sen univ

  • X

    Xu, Zhanxue

    sun yat sen univ

查看全部 14 位作者收起作者
  • C

    Cheng, Yuan

    2 · southern med univ

  • H

    Huang, Rufan

    sun yat sen univ

  • X

    Xie, Yuan

    sun yat sen univ

  • T

    Tsai, Hsiang-i

    jiangsu univ

  • Z

    Zha, Hualian

    sun yat sen univ

  • X

    Xi, Lifang

    sun yat sen univ

  • W

    Wang, Kai

    sun yat sen univ

  • C

    Cheng, Xiaoli

  • G

    Gao, Yanfeng

    sun yat sen univ

  • Z

    Zhang, Changhua (通讯)

    sun yat sen univ

  • C

    Cheng, Fang (通讯)

    sun yat sen univ

  • C

    Chen, Hongbo (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417